Acute respiratory distress syndrome pathophysiology: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Acute respiratory distress syndrome}} {{CMG}} ==Overview== Acute respiratory distress syndrome primarily results from the diffuse inflammation of lung parenchyma. Loss of aera...")
 
No edit summary
Line 33: Line 33:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Disease]]
[[Category:Intensive care medicine]]
[[Category:Pulmonology]]
[[Category:Syndromes]]
[[Category:Overview complete]]


[[es:Síndrome de distrés respiratorio agudo]]
[[es:Síndrome de distrés respiratorio agudo]]

Revision as of 16:52, 28 August 2012

Acute respiratory distress syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute respiratory distress syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic study of choice

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Mechanical Ventilation Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute respiratory distress syndrome pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute respiratory distress syndrome pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute respiratory distress syndrome pathophysiology

CDC on Acute respiratory distress syndrome pathophysiology

Acute respiratory distress syndrome pathophysiology in the news

Blogs on Acute respiratory distress syndrome pathophysiology

Directions to Hospitals Treating Acute respiratory distress syndrome

Risk calculators and risk factors for Acute respiratory distress syndrome pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Acute respiratory distress syndrome primarily results from the diffuse inflammation of lung parenchyma. Loss of aeration can cause fundamental changes in inflammation amplification and progression.

Pathophysiology

A pathohistological image of ARDS.
  • ARDS is characterized by a diffuse inflammation of lung parenchyma.
  • The triggering insult to the parenchyma usually results in an initial release of cytokines and other inflammatory mediators, secreted by local epithelial and endothelial cells.
  • Neutrophils and some T-lymphocytes quickly migrate into the inflamed lung parynchema and contribute in the amplification of the phenomenon.
  • Typical histological presentation involves diffuse alveolar damage and hyaline membrane formation in alveolar walls.
  • Although the triggering mechanisms are not completely understood, recent research has examined the role of inflammation and mechanical stress.

Inflammation

  • Inflammation alone, as in sepsis, causes:
  • Endothelial dysfunction
  • Fluid extravasation from the capillaries
  • Impaired drainage of fluid from the lungs
  • Dysfunction of type II pulmonary epithelial cells may also be present, with a concomitant reduction in surfactant production.
  • Elevated inspired oxygen concentration often becomes necessary at this stage, and they may facilitate a 'respiratory burst' in immune cells.
  • In a secondary phase, endothelial dysfunction causes cells and inflammatory exudate to enter the alveoli
  • This pulmonary edema increases the thickness of the alveolo-capillary space, increasing the distance the oxygen must diffuse to reach blood.
  • This impairs gas exchange leading to hypoxia, increases the work of breathing, eventually induces fibrosis of the airspace.
  • Rdema and decreased surfactant production by type II pneumocytes may cause whole alveoli to collapse, or to completely flood. This loss of aeration contributes further to the right-to-left shunt in ARDS.
  • As the alveoli contain progressively less gas, more blood flows through them without being oxygenated resulting in massive intrapulmonary shunting.
  • Collapsed alveoli (and small bronchi) do not allow gas exchange. It is not uncommon to see patients with a PaO2 of 60 mmHg (8.0 kPa) despite mechanical ventilation with 100% inspired oxygen.
  • The loss of aeration may follow different patterns according to the nature of the underlying disease, and other factors. In pneumonia-induced ARDS, for example, large, more commonly causes relatively compact areas of alveolar infiltrates.
  • Usually distributed to the lower lobes, in their posterior segments, and they roughly correspond to the initial infected area.
  • In sepsis or trauma-induced ARDS, infiltrates are usually more patchy and diffuse. The posterior and basal segments are always more affected, but the distribution is even less homogeneous.
  • Loss of aeration also causes important changes in lung mechanical properties. These alterations are fundamental in the process of inflammation amplification and progression to ARDS in mechanically ventilated patients.

References


Template:WikiDoc Sources